A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4412 (2006.01) A61P 11/00 (2006.01)
Patent
CA 2709997
Methods are provided for administering pirfenidone to a patient that has exhibited abnormal biomarkers of liver function in response to pirfenidone administration. The methods include administering to a patient pirfenidone at doses lower than the full target dosage for a time period, followed by administering to the patient pirfenidone at the full target dosage. The methods also include administering pirfenidone at the full target dose with no reduction and administering permanently reduced doses of pirfenidone.
La présente invention a pour objet des méthodes dadministration de pirfénidone à un patient qui a présenté des biomarqueurs anormaux de la fonction hépatique en réponse à ladministration de pirfénidone. Les méthodes comprennent ladministration à un patient de pirfénidone à des doses inférieures à la posologie cible complète pendant une période de temps, ceci suivi de ladministration au patient de pirfénidone à la posologie cible complète. Les méthodes comprennent également ladministration de pirfénidone à la posologie cible complète sans réduction et ladministration de manière permanente de doses réduites de pirfénidone.
Bradford Williamson Ziegler
Szwarcberg Javier
Intermune Inc.
Smart & Biggar
LandOfFree
Pirfenidone treatment for patients with atypical liver function does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pirfenidone treatment for patients with atypical liver function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pirfenidone treatment for patients with atypical liver function will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1772972